CoChat

Outcomes of Catheter Ablation of Ventricular Tachycardia Based on Etiology in Nonischemic Heart Disease

Open access
Vaseghi, Marmar, Hu, Tiffany Y., Tung, Roderick, Vergara, Pasquale, Frankel, David S., Di Biase, Luigi, Tedrow, Usha B., Gornbein, Jeffrey A., Yu, Ricky, Mathuria, Nilesh, Nakahara, Shiro, Tzou, Wendy S., Sauer, William H., Burkhardt, J. David, Tholakanahalli, Venkatakrishna N., Dickfeld, Timm-Michael, Weiss, J. Peter, Bunch, T. Jared, Reddy, Madhu, Callans, David J., Lakkireddy, Dhanunjaya R., Natale, Andrea, Marchlinski, Francis E., Stevenson, William G., Della Bella, Paolo, Shivkumar, Kalyanam · 2018 · JACC: Clinical Electrophysiology
Cited by 138

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background: Outcomes of catheter ablation of ventricular tachycardia (VT) in patients with non-ischemic cardiomyopathy (NICM) could be related to etiology of NICM. Objective: To characterize VT ablation outcomes across NICM etiologies and adjust these outcomes by patient related comorbidities that could explain differences in arrhythmia recurrence rates. Methods: Data from 2075 patients with structural heart disease referred for catheter ablation of VT from 12 international centers was retrospectively analyzed. Patient characteristics and outcomes were noted for the 6 most common NICM etiologies. Multivariable Cox proportional hazard model was used to adjust for potential confounders. Results: Of 780 NICM patients (57±14 years, 18% female, LVEF 37±13%) underlying prevalences were dilated idiopathic cardiomyopathy (DCM) 66%, arrhythmogenic right ventricular cardiomyopathy (ARVC) 13%, valvular cardiomyopathy 6%, myocarditis 6%, hypertrophic cardiomyopathy 4%, and sarcoidosis 3%. One-year freedom from VT was 69%; and freedom from VT, heart transplantation, and death was 62%. On unadjusted competing risk analysis, VT ablation in ARVC demonstrated superior VT-free survival (82%) vs. DCM (p≤0.01). Valvular cardiomyopathy had the poorest unadjusted VT-free survival at 47% (p<0.01). After adjusting for comorbidities, including age, heart failure severity, ejection fraction, prior ablation and anti-arrhythmic use, myocarditis, ARVC, and DCM demonstrated similar outcomes, while hypertrophic cardiomyopathy, valvular cardiomyopathy and sarcoidosis had the highest risk of VT recurrence. Conclusions: Catheter ablation of VT in NICM is effective. Etiology of NICM is a significant predictor of outcomes, with ARVC, myocarditis, and DCM having similar but superior outcomes to hypertrophic cardiomyopathy, valvular cardiomyopathy and sarcoidosis, after adjusting for potential covariates.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacep.2018.05.007

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 138

Metadata

Authors
Vaseghi, M., Hu, T. Y., Tung, R., Vergara, P., Frankel, D. S., Di Biase, L., Tedrow, U. B., Gornbein, J. A., Yu, R., Mathuria, N., Nakahara, S., Tzou, W. S., Sauer, W. H., Burkhardt, J. D., Tholakanahalli, V. N., Dickfeld, T.-M., Weiss, J. P., Bunch, T. J., Reddy, M., Callans, D. J., Lakkireddy, D. R., Natale, A., Marchlinski, F. E., Stevenson, W. G., Della Bella, P., & Shivkumar, K.
Venue
JACC: Clinical Electrophysiology
Publisher
Elsevier BV
Published
2018-09
Volume
4
Issue
9
Pages
1141-1150
ISSN
2405-500X (ISSN-L)
OpenAlex
W2883304559
Cited by
138
References
2
FWCI
8.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.